EP3923918A4 - Beta-hydroxybutyrate mixed salt-acid compositions and methods of use - Google Patents

Beta-hydroxybutyrate mixed salt-acid compositions and methods of use Download PDF

Info

Publication number
EP3923918A4
EP3923918A4 EP20755770.3A EP20755770A EP3923918A4 EP 3923918 A4 EP3923918 A4 EP 3923918A4 EP 20755770 A EP20755770 A EP 20755770A EP 3923918 A4 EP3923918 A4 EP 3923918A4
Authority
EP
European Patent Office
Prior art keywords
beta
methods
acid compositions
mixed salt
hydroxybutyrate mixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20755770.3A
Other languages
German (de)
French (fr)
Other versions
EP3923918A1 (en
Inventor
Gary MILLET
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Access Global Sciences LLC
Original Assignee
Access Global Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/272,145 external-priority patent/US10736861B2/en
Application filed by Access Global Sciences LLC filed Critical Access Global Sciences LLC
Publication of EP3923918A1 publication Critical patent/EP3923918A1/en
Publication of EP3923918A4 publication Critical patent/EP3923918A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP20755770.3A 2019-02-11 2020-02-06 Beta-hydroxybutyrate mixed salt-acid compositions and methods of use Pending EP3923918A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/272,145 US10736861B2 (en) 2016-03-11 2019-02-11 Mixed salt compositions for producing elevated and sustained ketosis
US16/720,211 US11020362B2 (en) 2016-03-11 2019-12-19 Beta-hydroxybutyrate mixed salt compositions and methods of use
PCT/US2020/016952 WO2020167571A1 (en) 2019-02-11 2020-02-06 Beta-hydroxybutyrate mixed salt-acid compositions and methods of use

Publications (2)

Publication Number Publication Date
EP3923918A1 EP3923918A1 (en) 2021-12-22
EP3923918A4 true EP3923918A4 (en) 2022-10-05

Family

ID=72045290

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20755770.3A Pending EP3923918A4 (en) 2019-02-11 2020-02-06 Beta-hydroxybutyrate mixed salt-acid compositions and methods of use

Country Status (6)

Country Link
EP (1) EP3923918A4 (en)
JP (2) JP2022520560A (en)
CN (1) CN113660930A (en)
AU (1) AU2020221031A1 (en)
CA (1) CA3129411A1 (en)
WO (1) WO2020167571A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112262936A (en) * 2020-10-22 2021-01-26 珠海麦得发生物科技股份有限公司 Beverage containing 3-hydroxybutyric acid and preparation method and application thereof
CN115251375A (en) * 2022-07-11 2022-11-01 珠海麦得发生物科技股份有限公司 (R) -3-hydroxybutyric acid ketonic product and preparation method thereof
WO2024067626A1 (en) * 2022-09-27 2024-04-04 南京纽邦生物科技有限公司 Composite of acid and salt, and preparation method therefor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170258745A1 (en) * 2016-03-11 2017-09-14 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1585817B1 (en) * 2002-02-20 2009-09-02 The General Hospital Corporation Conjugates comprising a biodegradable polymer and uses therefor
US8758740B2 (en) * 2007-03-30 2014-06-24 Earthus, Inc Composition for promoting ketone body production
TR201908522T4 (en) * 2008-01-04 2019-07-22 The Government Of The U S A As Represented By The Secretary Dept Of Health And Human Services Ketone bodies and ketone body esters as blood lipid lowering agents.
CA2902603C (en) * 2013-03-19 2021-03-02 University Of South Florida Compositions and methods for producing elevated and sustained ketosis
CA3021784A1 (en) * 2016-04-19 2017-10-26 Keto Patent Group, Inc. Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
US10588877B2 (en) * 2016-07-21 2020-03-17 Savind, Inc. Compositions comprising β-hydroxybutyric acid and salt, and methods of using the same
US20180057846A1 (en) * 2016-08-30 2018-03-01 KetoneAid Inc. Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
CA3053663C (en) * 2017-04-12 2021-09-07 Franco CAVALERI Butyrate and beta-hydroxybutyrate compositions and methods of use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170258745A1 (en) * 2016-03-11 2017-09-14 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis

Also Published As

Publication number Publication date
CN113660930A (en) 2021-11-16
AU2020221031A1 (en) 2021-09-02
WO2020167571A1 (en) 2020-08-20
JP2023166029A (en) 2023-11-17
CA3129411A1 (en) 2020-08-20
JP2022520560A (en) 2022-03-31
EP3923918A1 (en) 2021-12-22

Similar Documents

Publication Publication Date Title
EP4022059A4 (en) Oligonucleotide compositions and methods of use thereof
EP3959318A4 (en) Oligonucleotide compositions and methods of use thereof
EP3965780A4 (en) Oligonucleotide compositions and methods of use thereof
EP3923925A4 (en) Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
EP3962296A4 (en) Cannabinoid compositions and methods of using
EP3843720A4 (en) Compositions of cxcr4 inhibitors and methods of preparation and use
EP3923918A4 (en) Beta-hydroxybutyrate mixed salt-acid compositions and methods of use
EP3893917A4 (en) Il-15 compositions and methods of use thereof
EP3684369A4 (en) A33 antibody compositions and methods of using the same in radioimmunotherapy
EP3761972A4 (en) Bioreactive compositions and methods of use thereof
EP3749343A4 (en) Formulation and method of use
EP3829307A4 (en) Bismuth-thiol compositions and methods of use
EP3917543A4 (en) Enhanced nitrate compositions and methods of use
EP3856214A4 (en) Microbial compositions and methods of use
EP3768677A4 (en) Kv7 channel activators compositions and methods of use
EP3677126A4 (en) Ages inhibitor composition, use thereof, preparation method therefor, and formulation thereof
EP3934426A4 (en) Preservative compositions and methods of use thereof
EP3840769A4 (en) Cyclosporine compositions and methods of use
EP4045226A4 (en) Polishing compositions and methods of use thereof
EP4034605A4 (en) Polishing compositions and methods of use thereof
EP3941909A4 (en) Pi4-kinase inhibitors and methods of using the same
EP3774708A4 (en) Foxm1 inhibitor compositions and methods of using the same
EP3843555A4 (en) Anthocyanin-based colorant compositions and methods of use thereof
EP4054514A4 (en) Compositions containing fenchols and methods of use
EP4028023A4 (en) Compositions including molecules of modified mrna and methods of using the same

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210825

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220901

RIC1 Information provided on ipc code assigned before grant

Ipc: A23L 33/12 20160101ALI20220826BHEP

Ipc: A61P 3/00 20060101ALI20220826BHEP

Ipc: A61K 45/06 20060101ALI20220826BHEP

Ipc: A61K 31/593 20060101ALI20220826BHEP

Ipc: A61K 31/19 20060101ALI20220826BHEP

Ipc: A61K 31/12 20060101AFI20220826BHEP